It's important to note that when used as monotherapy, GLP-1 receptor agonists like semaglutide have a low risk of causing hypoglycemia
Choose a balanced eating pattern that is high in protein and minimizes foods that are high in fat and sugar, advises Isaacson
Study-specific documentation was submitted to the relevant national body, and the study was approved by the independent ethics committee or institutional review board for each participating centre
Yes, it is possible to switch from Ozempic to Wegovy, as both medications contain the same active ingredient, semaglutide
Eli Lilly has completed multiple Phase 3 trials and is expected to file for approval
See my options Research Snapshot Head-to-head comparison Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages